Literature DB >> 26320101

Clinical outcomes of patients with acute myeloid leukemia: evaluation of genetic and molecular findings in a real-life setting.

Aleide S Lima1, Mariana R de Mello2, Eliana Fernandes2, Matheus F Bezerra3, Mayara M Oliveira1, Bruno K Duarte2, Reijane A de Assis4, Fernanda R Souto4, Clarisa F Ramos2, Cintia G Machado4, Katia Pagnano2, Antonio R Lucena-Araujo3, Irene Lorand-Metze2, Marcos A Bezerra3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26320101     DOI: 10.1182/blood-2015-07-657551

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia.

Authors:  Matheus F Bezerra; Juan L Coelho-Silva; Jessica C Nascimento; Mariana T Benicio; Cintia R Rocha; Cintia G Machado; Eduardo M Rego; Marcos A Bezerra; Antonio R Lucena-Araujo; Eduardo I Beltrão
Journal:  Haematologica       Date:  2016-10-20       Impact factor: 9.941

2.  Influence of Dose Intensity in Consolidation with HIDAC and Other Clinical and Biological Parameters in the Survival of AML.

Authors:  Ricardo Ballesteros-Ramírez; Sandra Quijano; Julio Solano; Camila Ordoñez-Reyes; María V Herrera; Raúl Murillo; Susana Fiorentino; Mónica Arevalo-Zambrano
Journal:  J Cancer Epidemiol       Date:  2020-06-24

3.  Overall survival of Brazilian acute myeloid leukemia patients according to the European LeukemiaNet prognostic scoring system: a cross-sectional study.

Authors:  Tarcila Santos Datoguia; Elvira Deolinda Rodrigues Pereira Velloso; Ricardo Helman; Juliane Garcez Musacchio; Marco Aurélio Salvino; Rodolfo Almeida Soares; Marcia Higashi; Adriana Valente Fadel; Rodrigo Santucci Alves E Silva; Nelson Hamerschlak; Fabio Pires de Souza Santos; Paulo Vidal Campregher
Journal:  Med Oncol       Date:  2018-09-05       Impact factor: 3.064

4.  Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia-Real-World Context.

Authors:  Nikhil Patkar; Chinmayee Kakirde; Prasanna Bhanshe; Swapnali Joshi; Shruti Chaudhary; Yajamanam Badrinath; Sitaram Ghoghale; Nilesh Deshpande; Shraddha Kadechkar; Gaurav Chatterjee; Sadhana Kannan; Dhanalaxmi Shetty; Anant Gokarn; Sachin Punatkar; Avinash Bonda; Lingaraj Nayak; Hasmukh Jain; Bhausaheb Bagal; Hari Menon; Manju Sengar; Syed Hasan Khizer; Navin Khattry; Prashant Tembhare; Sumeet Gujral; Papagudi Subramanian
Journal:  Front Oncol       Date:  2019-06-13       Impact factor: 6.244

5.  C-Type Lectin-Like Molecule-1 as a Biomarker for Diagnosis and Prognosis in Acute Myeloid Leukemia: A Preliminary Study.

Authors:  Jinghua Wang; Weida Wang; Hao Chen; Wenmin Li; Tian Huang; Weiya Zhang; Wei Ling; Peilong Lai; Yulian Wang; Suxia Geng; Minming Li; Xin Du; Jianyu Weng
Journal:  Biomed Res Int       Date:  2021-03-11       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.